Last updated: 2025-06-06
Checks: 1 1
Knit directory: multigroup_ctwas_analysis/
This reproducible R Markdown analysis was created with workflowr (version 1.7.0). The Checks tab describes the reproducibility checks that were applied when the results were created. The Past versions tab lists the development history.
The R Markdown file has unstaged changes. To know which version of
the R Markdown file created these results, you’ll want to first commit
it to the Git repo. If you’re still working on the analysis, you can
ignore this warning. When you’re finished, you can run
wflow_publish
to commit the R Markdown file and build the
HTML.
Great! You are using Git for version control. Tracking code development and connecting the code version to the results is critical for reproducibility.
The results in this page were generated with repository version db13c36. See the Past versions tab to see a history of the changes made to the R Markdown and HTML files.
Note that you need to be careful to ensure that all relevant files for
the analysis have been committed to Git prior to generating the results
(you can use wflow_publish
or
wflow_git_commit
). workflowr only checks the R Markdown
file, but you know if there are other scripts or data files that it
depends on. Below is the status of the Git repository when the results
were generated:
Ignored files:
Ignored: .Rhistory
Ignored: cv/
Unstaged changes:
Modified: analysis/realdata_final_genefunctions.Rmd
Note that any generated files, e.g. HTML, png, CSS, etc., are not included in this status report because it is ok for generated content to have uncommitted changes.
These are the previous versions of the repository in which changes were
made to the R Markdown
(analysis/realdata_final_genefunctions.Rmd
) and HTML
(docs/realdata_final_genefunctions.html
) files. If you’ve
configured a remote Git repository (see ?wflow_git_remote
),
click on the hyperlinks in the table below to view the files as they
were in that past version.
File | Version | Author | Date | Message |
---|---|---|---|---|
Rmd | db13c36 | XSun | 2025-06-06 | update |
html | db13c36 | XSun | 2025-06-06 | update |
Rmd | 00be92f | XSun | 2025-06-03 | update |
html | 00be92f | XSun | 2025-06-03 | update |
Rmd | 0a2aa7f | XSun | 2025-05-30 | update |
html | 0a2aa7f | XSun | 2025-05-30 | update |
html | 28a04c5 | XSun | 2025-05-29 | update |
Rmd | bd07e51 | XSun | 2025-05-29 | update |
html | bd07e51 | XSun | 2025-05-29 | update |
Rmd | 1cec535 | XSun | 2025-05-29 | update |
html | 1cec535 | XSun | 2025-05-29 | update |
https://sq-96.github.io/multigroup_ctwas_analysis/realdata_final_multigroup_summary.html
LDLR, PCSK9, CETP, CCNJ, PKN3, ABCA8, FCGRT, DNAJC13, LRCH4, HMGCR, ASGR1, APOB, ADH1B, FLT3, ZDHHC18, USP39, TIMD4, ZFYVE1, ACP6, NPC1L1, ERGIC3, MITF, PSRC1, SNX17, GABBR1, HMGN1, KIF13B, R3HDM2, MYPOP, SIPA1, USP3, PGS1, FAM117B, ADRB1, PHC1, WASHC4, TPD52, THOP1, ZFP28, DMTN, PDE4C, XPNPEP3
Genes with Strong Evidence of Association with LDL Cholesterol
LDLR (Low-Density Lipoprotein Receptor): Mutations in LDLR are a primary cause of familial hypercholesterolemia, leading to elevated LDL cholesterol levels due to impaired clearance of LDL particles from the bloodstream.
PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9): PCSK9 regulates LDL receptor degradation. Gain-of-function mutations increase LDL cholesterol levels, while loss-of-function mutations are associated with reduced LDL cholesterol and a lower risk of coronary heart disease.
APOB (Apolipoprotein B): APOB encodes the primary protein component of LDL particles. Mutations can impair LDL binding to its receptor, resulting in elevated LDL cholesterol levels.
CETP (Cholesteryl Ester Transfer Protein): CETP facilitates the transfer of cholesteryl esters from HDL to LDL and VLDL particles. Variants in CETP can influence HDL and LDL cholesterol levels.
HMGCR (3-Hydroxy-3-Methylglutaryl-CoA Reductase): This enzyme is the rate-limiting step in cholesterol biosynthesis and is the target of statin therapy. Variants in HMGCR can affect LDL cholesterol levels.
NPC1L1 (Niemann-Pick C1-Like 1): NPC1L1 is critical for intestinal cholesterol absorption. Inhibitors like ezetimibe target this protein to reduce LDL cholesterol levels.
ASGR1 (Asialoglycoprotein Receptor 1): Loss-of-function mutations in ASGR1 have been associated with reduced LDL cholesterol levels and a lower risk of coronary artery disease.
PSRC1 (Proline and Serine Rich Coiled-Coil 1): Variants near PSRC1 have been linked to LDL cholesterol levels in genome-wide association studies (GWAS).
TIMD4 (T-cell Immunoglobulin and Mucin Domain Containing 4): Variants in TIMD4 have been associated with decreased serum triglyceride levels and a reduced risk of coronary heart disease and ischemic stroke in certain populations.
PARP9,DDX56,MZF1,CLDN23,FUT2,VIL1,KLHDC7A,WBP1L
Genes with No Strong or Established Evidence for LDL Association
DDX56 RNA helicase with roles in ribosome biogenesis; no known links to lipid metabolism or LDL levels.
MZF1 A transcription factor; not directly linked to lipid or cholesterol traits.
VIL1 Villin 1, an actin-binding protein in the intestinal brush border; no direct LDL link known.
WBP1L Not currently known to be involved in lipid metabolism or LDL levels.